Oligonucleotide purity is critical for therapeutic performance, yet achieving high-purity samples can be challenging. During synthesis, closely related impurities and failed sequences can complicate analysis and compromise product quality. Effective characterization methods support confident identification and separation of target oligos to maintain quality and streamline production.
Download this infographic to learn:
- Techniques for identifying impurities and optimizing oligonucleotide synthesis
- Approaches for detailed target and impurity analysis
- Workflow options for effective separation, detection, and data analysis
